Metformin is increasingly used in the treatment of GDM, however its use in pregnancy is still controversial due to the lack of convincing long-term offspring safety data [31] and, therefore, insulin is the first-line agent in many countries, including the US also [7]. This evidence concerns the gene INS and gestational diabetes.